K. Naber, G. Schito, H. Botto, J. Palou, and T. Mazzei, Surveillance Study in Europe and Brazil on Clinical Aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): Implications for Empiric Therapy, European Urology, vol.54, issue.5, pp.1164-75, 2008.
DOI : 10.1016/j.eururo.2008.05.010

C. Costelloe, C. Metcalfe, A. Lovering, D. Mant, and A. Hay, Effect of antibiotic prescribing in primary care 358 on antimicrobial resistance in individual patients: systematic review and meta-analysis, BMJ, vol.359340, pp.2096-360, 2010.

A. Manges, J. Johnson, B. Foxman, O. Bryan, T. Fullerton et al., Widespread distribution of 361 urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group, N Engl J Med, vol.362345, issue.14, pp.1007-1310, 0363.

J. Pitout and K. Laupland, Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an 364 emerging public-health concern. The Lancet Infectious diseases, pp.159-6610, 2008.

B. Rogers, H. Sidjabat, and D. Paterson, Escherichia coli O25b-ST131: a pandemic, multiresistant, 367 community-associated strain. The Journal of antimicrobial chemotherapy, pp.1-14, 2011.

A. Carbonne, I. Arnaud, S. Maugat, N. Marty, C. Dumartin et al., National multidrug- 370 resistant bacteria (MDRB) surveillance in France through the RAISIN network: a 9 year experience, p.371

M. Nicolas-chanoine, C. Gruson, S. Bialek-davenet, X. Bertrand, F. Thomas-jean et al., 10-Fold 373 increase (2006-11) in the rate of healthy subjects with extended-spectrum beta-lactamase-producing 374

V. Jarlier, M. Nicolas, G. Fournier, and A. Philippon, Extended Broad-Spectrum ??-Lactamases Conferring Transferable Resistance to Newer ??-Lactam Agents in Enterobacteriaceae: Hospital Prevalence and Susceptibility Patterns, Clinical Infectious Diseases, vol.10, issue.4, pp.867-78, 1988.
DOI : 10.1093/clinids/10.4.867

D. Champs, C. Chanal, C. Sirot, D. Baraduc, R. Romaszko et al., Frequency and diversity of Class A extended-spectrum ??-lactamases in hospitals of the Auvergne, France: a 2 year prospective study, Journal of Antimicrobial Chemotherapy, vol.54, issue.3, pp.634-643, 2004.
DOI : 10.1093/jac/dkh395

C. Eckert, V. Gautier, M. Saladin-allard, N. Hidri, C. Verdet et al., Dissemination of CTX- 411 M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrobial 412 agents and chemotherapy, pp.1249-55, 2004.

A. Magiorakos, A. Srinivasan, R. Carey, Y. Carmeli, M. Falagas et al., Multidrug-resistant, 414 extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for 415 interim standard definitions for acquired resistance. Clinical microbiology and infection : the official 416 publication of the European Society of Clinical Microbiology and Infectious Diseases, pp.268-417, 2012.

S. Lemeshow, L. Letenneur, J. Dartigues, S. Lafont, J. Orgogozo et al., Illustration of Analysis Taking into Account Complex Survey Considerations: The Association between Wine Consumption and Dementia in the PAQUID Study, American Journal of Epidemiology, vol.148, issue.3, pp.298-306, 1998.
DOI : 10.1093/oxfordjournals.aje.a009639

. Insee, Estimations de population, pyramide des âges au 1er janvier 2012, 2015.

T. Lumley, A. Kronenberg, S. Koenig, S. Droz, and K. Muhlemann, Analysis of complex survey samples Active surveillance of antibiotic resistance 426 prevalence in urinary tract and skin infections in the outpatient setting. Clinical microbiology and 427 infection : the official publication of the European Society of Clinical Microbiology and Infectious 428 Diseases, Journal of Statistical Software, vol.917, issue.112, pp.1-19, 2004.

K. Laupland, D. Church, J. Vidakovich, M. Mucenski, and J. Pitout, Community-onset extended- 430 spectrum beta-lactamase (ESBL) producing Escherichia coli: importance of international travel. The 431, Journal of infection, vol.57, issue.6, 2008.

G. Kahlmeter and H. Poulsen, Antimicrobial susceptibility of Escherichia coli from community- 433 acquired urinary tract infections in Europe: the ECO.SENS study revisited. International journal of 434 antimicrobial agents, pp.45-51, 2012.

T. Hooton, R. Besser, B. Foxman, T. Fritsche, L. A. Nicolle et al., Acute uncomplicated cystitis in an era of 438 increasing antibiotic resistance: a proposed approach to empirical therapy Clinical infectious 439 diseases : an official publication of the Infectious Diseases Society of America Are resistance patterns in uropathogens published by 443 microbiological laboratories valid for general practice? APMIS : acta pathologica, microbiologica, et 444 immunologica Scandinavica, pp.75-80676, 1999.

G. Cornaglia, W. Hryniewicz, V. Jarlier, G. Kahlmeter, H. Mittermayer et al., European 446 recommendations for antimicrobial resistance surveillance. Clinical microbiology and infection : the 447 official publication of the European Society of Clinical Microbiology and Infectious Diseases, pp.349-83, 2004.

M. Etienne, E. Lefebvre, N. Frebourg, H. Hamel, M. Pestel-caron et al., Antibiotic treatment of acute uncomplicated cystitis based on rapid urine test and local epidemiology: lessons from a primary care series, BMC Infectious Diseases, vol.67, issue.1, pp.137-147, 2014.
DOI : 10.1093/jac/dks222

J. Warren, E. Abrutyn, J. Hebel, J. Johnson, A. Schaeffer et al., Guidelines for 455 antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. 456 Infectious Diseases Society of America (IDSA) Clinical infectious diseases : an official publication of 457 the Infectious Diseases Society of America, pp.745-5810, 1999.

G. Zhanel, T. Hisanaga, N. Laing, M. Decorby, K. Nichol et al., Antibiotic 459 resistance in Escherichia coli outpatient urinary isolates: final results from the North American 460

K. Keating, E. Perfetto, and P. Subedi, Economic burden of uncomplicated urinary tract infections: direct, indirect and intangible costs, Expert Review of Pharmacoeconomics & Outcomes Research, vol.5, issue.4, pp.457-66, 2005.
DOI : 10.1586/14737167.5.4.457